Skip to main content

Table 4 Relative expression levels of RBM5 in chimeric positive versus chimeric negative tumour samples compared to non- tumour

From: RBM6-RBM5 transcription-induced chimeras are differentially expressed in tumours

  RBM5 (mean ± SD) Control (S28) (mean ± SD) normalized RBM5 fold change in tumour compared to non-tumour
Breast Tissue     
tumour     
   chimeric transcript (+) 0.073 ± 0.001 0.013 ± 0.001 5.615 35.31
   chimeric transcript (-) 0.041 ± 0.005 0.029 ± 0.004 1.413 8.886
non-tumour 0.017 ± 0.003 0.107 ± 0.005 0.159 1
  1. (+) : chimeric transcript positive, (-) : chimeric transcript negative.